RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
 ALNY | Alnylam Pharmaceuticals, Inc. | $27.5b | $232.29 | +4.4% | 2.4M |
 ARWR | Arrowhead Research Corporation | $11.9b | $88.51 | -3.0% | 1.4M |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $8.6b | $53.80 | -1.6% | 1.6M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $1.1b | $6.06 | -1.0% | 1.4M |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $241.3m | $1.98 | +7.9% | 1.3M |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $231.2m | $8.38 | +3.6% | 97.6K |
 RNA | Atrium Therapeutics, Inc. Common Stock | $193.8m | $11.75 | +2.0% | 157.8K |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $179.1m | $4.17 | -3.1% | 74.2K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $12.0m | $1.07 | -0.5% | 54.0K |
 XCUR | Exicure, Inc. Common Stock | $10.1m | $1.46 | -3.9% | 24.6K |